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Crohn’s disease is a chronic granulomatous inﬂammatory disease of the gastrointestinal tract, which can involve almost any seg-
ment from the mouth to the anus. Typically, Crohn’s lesions attain segmental and asynchronous distribution with varying levels of
seriousness, although the sites most frequently involved are the terminal ileum and the proximal colon. A single gold standard for
the diagnosis of CD is not available and the diagnosis of CD is conﬁrmed by clinical evaluation and a combination of endoscopic,
histological, radiological, and/or biochemical investigations. In recent years, many studies have been performed to investigate the
diagnostic potential of less invasive and more patient-friendly imaging modalities in the evaluation of Crohn’s disease includ-
ing conventional enteroclysis, ultrasonography, color-power Doppler, contrast-enhanced ultrasonography, multidetector CT ente-
roclysis, MRI enteroclysis, and 99mTc-HMPAO-labeled leukocyte scintigraphy. The potential diagnostic role of each imaging
modality has to be considered in diﬀerent clinical degrees of the disease, because there is no single imaging technique that allows a
correct diagnosis and may be performed with similar results in every institution. The aim of this paper is to point out the advan-
tages and limitations of the various imaging techniques in patients with suspected or proven Crohn’s disease.
1. ConventionalEnteroclysis(CE)
Conventional enteroclysis is generally performed according
to the technique established by Herlinger [1].
A nasoenteric tube is placed beyond the duodenojejunal
junction under ﬂuoroscopic guidance. A standard amount
of barium (300mL) and 0.5% methylcellulose solution
(1.500mL) or air, as in our experience, is infused through
the nasoenteric tube, achieving optimal double-contrast and
small-bowel distention.
Standardized compression views are obtained in all pa-
tients for evaluation of the small bowel, especially of the ter-
minal ileum [2].
Crohn’s disease has been traditionally investigated with
the use of small bowel barium enteroclysis, which detects
earlymucosaldisease(sens.69.6%,spec.95.8%[3])aswellas
complicationssuchasstrictures,ﬁstulae,andabscesses(diag-
nostic accuracy 80.3%) [3, 4].
Radiologic ﬁndings include irregular thickening and dis-
tortion of the valvulae conniventes, loops adhesions (mass-
like eﬀect), or separated loops because of wall thickening and
mesenteric inﬂammatory inﬁltration [5]( Figure 1).
Transverse and longitudinal distribution of ulcerations
can separate islands of thickened internal wall, resulting in
the typical cobblestone appearance.
Strictures are often separated by healthy bowel tracts
(skip lesions); impaired small bowel peristalsis is commonly
observed within rigid stenotic tracts. Extrinsic compression
may be observed, due to mesentery lymph node enlargement
[6]. In partial obstructing stenosis, enteroclysis may provide
higher sensitivity than enterography for detection of lesions
in the small bowel [7].
Althoughitmanagestoaccuratelydetectthelocationand
extension of Crohn’s disease (sens. 98%, spec. 97% [8]), it is
unable to provide information on extraluminal lesions [9],
and capsule endoscopy and double balloon enteroscopy have2 Gastroenterology Research and Practice
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Figure 1: Conventional enteroclysis. (a) Conventional enteroclysis: panoramic view. (b) Mild wall thickening in the ileum. (c) Scattered
linear aphthoid lesions (arrow) in a segment of distal small bowel. (d) Mucosal ulcers (arrows). (e) Typical cobblestone-like nodular ﬁlling
defects and ulceration. (f) Fistula (arrows). (g) Stenotic loop (arrows).
replaced the enteroclysis as gold standard technique, even in
clinical practice [7].
However, barium enteroclysis may be required as an ad-
ditional test in a small group of patients with a high clinical
suspicion but a negative CT study [10].
2. Ultrasonography (US)
Ultrasonography is an accurate, noninvasive, painless diag-
nostictoolwiththecapabilityofbeingusedextensivelyinthe
clinical setting.
The examination consist of a global evaluation of the
small bowel and colon with standard resolution US (3.5–
5MHz), followed by a focused high-resolution study (7–
12MHz). B-mode US may visualize ﬁve concentric layers
with diﬀerent echogenicities [11].
The ﬁrst layer is the echogenic interface, followed by a
hypoechoic mucosa, an echogenic submucosa, a hypoechoic
muscular layer, and a echogenic interface between the serosa
and the adjacent fatty mesentery [12].
Each layer does not correspond exactly to a deﬁned his-
tologic layer but rather an interface between adjacent layers
[13].
The normal thickness of the small bowel is comprised
≤3 in the distended bowel and ≤5mm in the nondistended
bowel.
Intestinal US allows the visualization of wall thickening
oftherelevantloop,withthelossofnormalstratiﬁcationand
motility, lackofcompressibilitybythetransducer,narrowing
of the lumen, conglomeration, the possible coexistence of
mesenteric thickening, increased lymph nodes, abdominal
ﬂuid and abscess, ﬁstulas and stenoses related to dilations of
the upper loops [7, 11]( Figure 2).
However, the accuracy of US is highly dependent on fac-
torssuchasexperiencelevelofexaminingphysicianandloca-
tion and severity of the disease [7].
When sensitivity is estimated based on disease location,
the highest values are found for anatomic areas easily acces-
sible by US, such as terminal ileum and left colon, whereas
the diagnostic accuracy is lower for upper small bowel and
rectum [14].Gastroenterology Research and Practice 3
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Figure 2:US.(a)Wallthickeningwithoutstratiﬁcationandhyperecoiclumen.Regularoutermarginoftheloop.Mesentericfathypertrophy.
(b) Coexistence of two patterns. Stenotic and thickened loop with preserved stratiﬁcation and an adjcent segment with loss of stratiﬁcation.
(c) Stenotic intestinal tract characterized by marked dilatation of the bowel lumen, with thickened bowel wall. (d) Wall thickening with loss
of normal stratiﬁcation. Discontinuous outer margin with hypoecoic indented irregularities due to extramural ﬁndings.
Ultrasonography has the further disadvantage of being
diﬃcult to perform on overweight patients aﬀected by severe
meteorism.Furthermore,anultrasoundexamdoesnotallow
operators to detect superﬁcial intramural lesions [15–17].
The signiﬁcant heterogeneity of the estimates of diag-
nostic accuracy (sensitivity 75–94% and speciﬁcity 67–100%
[18];sensitivityandspeciﬁcity90%and96%[19];sensitivity
and speciﬁcity 85% and 98% [7]; sens. 92% and spec. 97%
[8])precludedthepossibilityofobtainingacumulativevalue
of diagnostic accuracy.
In general, the magnitude of US changes has a high cor-
relation with endoscopic and histological magnitude of alte-
rationsandaweakcorrelationwithindexesofclinicalactivity
and biomarkers [7], especially in ﬁstulae (sens. 71.4%, spec.
95.8%,acc.85.2%)andabscesses(acc.88.5%)evaluation[3].
Moreover, the bowel hydrosonography (with oral nonab-
sorbable solution) results in an increase in the sensitivity of
US for the detection of segments with active disease [20].
To date, sonography of intestinal loops is useful as the
preliminary examination [21], can help in clinical diagnostic
conﬁdence, and can provide important diagnostic ﬁndings,
suggesting the use of the other imaging technique. The use
of US has also been proposed in the followup of patients
with known Crohn’s disease in asymptomatic patients in
ordertoidentifytheoccurrenceofcomplicationsatanearlier
stage [22] and recurrences (diagnostic accuracy 72.7%)
[23].
AllstudiesshowedahighaccuracyofUSforthediagnosis
ofpostsurgicalrecurrenceinCD,detectingalmostallcasesof
severe or complicated recurrence, as well as high sensitivity
andspeciﬁcityindiﬀerentiatingmildfromsevererecurrence,
especially after giving oral contrast [7].
US has demonstrated a high diagnostic accuracy for the
detectionofsmallbowelﬁstulae,abscesses,andstenosis[24].
For the detection of internal ﬁstulas, the combination
of small bowel enteroclysis and US signiﬁcantly improved
diagnostic accuracy (small bowel enteroclysis 84%, US 85%,
combination 91%) [7].
In conclusion, in known Crohn’s disease for following
disease course and evaluating relapses and extramural man-
ifestations, US is an excellent tool (sens. 88.4%, 93.3%, acc.
90.4%) [25].4 Gastroenterology Research and Practice
3. Color-Power Doppler (PD)
Color and power Doppler US permits the measurement of
arterial and venous ﬂows in the upper mesenteric vessels, the
evaluationoftheincreaseoftherelevantloop, determination
of alterations in the vascular and microvascular nature of the
inﬂammatory process and association with neoangiogenesis
in the intestinal wall [26].
Color and power Doppler imaging usually is performed
with parameters optimized to detect low velocity and low-
ﬂow states (pulse repetition frequencies 800–1500Hz, wall
ﬁlter40–50Hz,maximalcolorsignalgainimmediatelybelow
the noise threshold, high levels of color versus echo priority,
and color persistence) [13].
The intensity of the vascularity may be subjectively cat-
egorized as mild (small focal area of color signal), moderate
(multiples areas of weak color signal), or marked (multiple
areas of color signal) because some studies have found that
increased vascularity of the diseased bowel wall correlates
with the activity of the disease [26].
Dopple, sonographic parameters of superior mesenteric
artery are signiﬁcantly correlated with disease activity in
nonoperated and noncomplicated Crohn’s disease [27].
CombinationofB-modeandpowerDopplersonography
hasahighaccuracyinthedeterminationofdiseaseactivityin
Crohn’s disease when compared to ileocolonoscopy [27].
To date, the use of power Doppler US has been suggested
to improve the diagnostic accuracy of US, particularly in dis-
criminating inﬂammatory from ﬁbrotic strictures, in better
deﬁning the presence of internal ﬁstulas, and to diﬀerentiate
these lesions from intra-abdominal abscesses [13, 15–19, 21,
22, 28]( Figure 3).
4. Contrast-EnhancedUltrasonography (CEUS)
The limit of US evaluation is the impossibility of assessing
bowel wall vascularization and the diﬀerentiation between
thickening due to active inﬂammation or ﬁbrosis cannot be
reliably made with ultrasound. However, the bowel wall neo-
vascularization is an early pathological change occurring in
patients with active CD [29].
The availability of dedicated contrast-speciﬁc techniques
overcomes the limitations of CD-US with microbubble con-
trastagents,includingbloomingartifactsandthelimitedvis-
ibility of vessels with a slowﬂow [13] and has enabled ultra-
sonography to obtain information regarding the perfusion
behavior of the organs and their diﬀuse or focal diseases
[30].
Microbubble contrast agents are mainly blood-pool
agents and present a pure intravascular distribution and
allow to increase the backscatter signal from blood cells.
Microbubblesconsistofsmallgasparticleswithadiameterof
2–6µm with a stiﬀ or ﬂexible shell composed by biocompati-
ble materials (proteins, lipids, or biopolymers) presenting an
overall thickness from 10 to 200nm.
Insonation techniques are available for CEUS. The high-
transmit-power insonation produces extensive microbubble
destruction with the production of a wide-band irregu-
lar harmonic signal. Low-transmit-power insonation (about
30–70 KPa) produces microbubble resonance with produc-
tion of regular harmonic frequencies and allows real-time
scanning, and it is the technique of insonation which is usu-
ally in the clinical practice.
Now are available also specialized contrast-speciﬁc US
techniques, such as pulse inversion, recognition imaging,
power modulation, and contrast pulse sequence [31].
CEUS provides an adequate evaluation of the increased
parietal vascularization in the active phase of the Crohn dis-
ease. It might help in characterizing bowel-wall thickening
by diﬀerentiating inﬂammatory vascularization, edema, and
ﬁbrosis and may help to grade disease activity by assessing
the presence and distribution of vascular perfusion within
the layers of the bowel wall, although it is limited to the eva-
luation of a speciﬁc loop (Figure 4).
Four diﬀerent perfusion patterns of bowel enhancement
related to Crohns activity have been recently proposed: (a)
a complete enhancement of the entire wall section, from the
mucosal to the serosal layer; (b) the absence of enhancement
only in the outer border of the muscularis propria; (c) the
absence of enhancement both in the outer and in the inner
border of the bowel wall and enhancement only in the inter-
mediate layer; (d) the complete absence of enhancement in
the entire wall section [29].
Contrast-enhanced US could classify severity signiﬁ-
cantly better than Doppler-US signal and measurement of
mural thickening (P<0.001) [32].
Patients with Crohn’s disease require frequently multiple
imaging examinations. CEUS is a noninvasive technique,
which is also more comfortable for the patient with signif-
icant diagnostic accuracy. The high sensitivity and temporal
resolution of CEUS in the assessment of small bowel vascu-
larity is the real strength of this technique [30].
CEUS can become the most useful imaging modality in
the diﬀerential diagnosis between ﬁbrotic and inﬂammatory
thickening, in the detection of possible disease complications
(abscess, phlegmons, and ﬁstulas) and for assessing the eﬃ-
cacyofmedicaltherapyinreducingbowel-wallvascularityin
patients with chronic inﬂammatory disease.
To date, one study evaluated the accuracy of contrast-
enhanced US for assessment of activity in CD, showing that
the technique has a high sensitivity and speciﬁcity (93% and
94%, resp.) [33], (sens. 81%, spec. 63% for semiquantitative
method; sens. 81%, spec. 55.6% for quantitative method)
[29].
The comparison of the diagnostic accuracy of conven-
tionalUS,DopplerUS,andcontrast-enhancedUSforassess-
ment of disease activity showed that the sensitivity of three
modalities of examination and speciﬁcity are virtually iden-
tical (94, 94, 94% and 97, 97, 97%, resp.) [33].
In conclusion, CEUS has a high sensitivity and speciﬁcity
in detecting inﬂammatory activity and a strong correlation
with the CDAI (sens. 93.5%, spec. 93.7%, acc. 93.6%, corre-
lation coeﬃcient 0.74; P<0.0001) [33].
CEUS allows real-time assessment of the bowel-wall per-
fusion with the highest temporal resolution of all imaging
techniques and with a spatial and contrast resolution that
rivals that of CT and MRI. In consideration of the need for
patientcomfort,especiallyinpediatricimaging,CEUSmightGastroenterology Research and Practice 5
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Figure 3: PDs. Wall thickening in B mode (a), in PD (b), (c), (d), and arterial doppler spectrum (e).
(a) (b)
(c) (d)
Figure 4: CEUS. Last ileal loop wall thickening and submucosal contrast enhancement after contrast medium (SonoVue, Bracco). 0 (a), 15
(b), 30 (c), and 45 (d) sec.6 Gastroenterology Research and Practice
become the most useful modality for assessing the eﬃcacy of
medical therapy with chronic inﬂammatory disease.
The routine use of the CEUS in the clinical assessment of
the patient with active Crohn’s disease for therapeutical and
surgical management should be suggested [33].
5.MultidetectorCTEnteroclysis(MDCT-E)
Multidetector CT enteroclysis was introduced as an alterna-
tive imaging method to overcome the individual deﬁciencies
of CT and conventional enteroclysis and to combine the
advantages of both in one technique.
MDCT-E has been described as highly accurate in reveal-
ing mural and extraluminal manifestations of disease, in-
cluding abscesses, while conventional enteroclysis was supe-
rior for luminal abnormalities and ulceration (Figure 5)[ 34,
35].
CT enteroclysis can be performed by using positive ent-
eral contrast material without intravenous contrast material
orneutralenteralcontrastmaterialwithintravenouscontrast
material [36].
The advantages of neutral CM through the lumen out-
weighthoseoﬀeredbypositiveCMforthefollowingreasons:
lower costs, low viscosity, faster injections, and better view of
enhancement, wall thickening, and mesenteric involvement.
Positive CM through the lumen is useful in the case of con-
traindications to CM intravenously injected. As far as our
study is concerned, we combined neutral and intra-venously
injected CM through the lumen in all patients [37].
Inourexperience,beforetheexam,patientstakelaxatives
for small-bowel and colon cleansing. Then a nasoenteric
tube—150cm long, 21mm in diameter, 2.8mm in external
diameter, and a distal end closed by a plastic tip with 4 side
holes[Guerbet,Paris]—isplaced.Thepatientismovedtothe
CT room where scout-view and volumetric scan are carried
out.
A layer not wider than 3mm and a reconstructing inter-
val not larger than 5mm are chosen.
20mg of hyoscine butylbromide are administered intra-
venouslyin orderto reduceintestinal peristalsis andsegmen-
tation of the intestinal loops and foster their distension.
1800mLofwaterattemperature37◦Cisusedasaneutral
contrast agent and administered through a peristaltic pump
so as to obtain a suitable distension of the intestinal loops.
The initial 500mL is ﬂushed through the tube at a speed
of 120mL/min in order to avoid stress caused by sudden
loosening. Then the inoculation of another 1000mL at
240mL/min follows, with the aim of loosening the loops
and pushing the contrast medium (CM) forward. The last
300mL is injected at 120mL/s.
Afterintroducing1500mLofintraluminalcontrastmed-
ium, iodinated contrast agent is injected intravenously, 1mg
iodine/kg body weight (BW) through a mechanic injector
at a concentration of 400mg iodine/mL (“Iomeprol” and
“‘Iomeron 400”’ Bracco, Italy) with a 80s delay in scanning.
In the ﬁrst 40s, the CM is injected at a speed of 1mL/s,
whereas in the remaining 30s it is administered at a speed
of 3mL/s. The exam is carried out with one volumetric acq-
uisition at 70s during breathing-in apnea, thus reducing the
CT-dependent patient’s dose. CT images are analyzed on
a soft-tissue window (30-HUcenter level, 400-HU-window
width).
Multiplanar reconstructions are undertaken in all pa-
tients to help interpret conﬂicting ﬁndings in axial scans, im-
prove the detection of lesions, and increase the capability for
assessing lesions’ extension.
Patients with the disease do not form a clinically homo-
geneousgroup,andtheymaybeverydiﬀerentfromoneano-
ther, with diﬀerent clinical situations inﬂuenced by individ-
ual expression of the disease and possible previous surgical
procedures; this does not always allow a uniform and rep-
roducibleclinicalandradiologicalstandardizationofthedis-
ease [38, 39].
In patients suspected of having Crohns disease, MDCT-E
is accurate in depicting mucosal abnormalities, bowel thick-
ening, mucosa hyperemia, ulcers, stenosis, engorgement of
vasa recta, and lymph nodes and mesenteric involvement
[40–42].
It is superior to CT enterography in that it provides a sui-
table uniform distension of the lumen, thus allowing assess-
ment of wall thickness [43].
Evidence suggest a high sensitivity, speciﬁcity, and accu-
racy in the evaluation of relapse of ileocolic anastomosis [7].
It also has higher sensitivity and greater interobserver
reliability if compared to MR enteroclysis and does not entail
any risk of capsule retention to the patient while performing
video capsule endoscopy [44].
Nonetheless, MDCT-E has its drawbacks. Take for ins-
tance, ionizing radiation, time needed for placing the naso-
enteric tube, high costs, contrast medium intravenously in-
jected, likely inhalation of contrast medium injected into the
lumen, necessity to attain a suitable distension of the lumen,
and lower sensitivity when it comes to identifying lesions of
the mucosa and jejunum.
Diﬀerences in speciﬁcity and sensitivity can be ascribed
to a distinct lack of standard protocols [45–49] and to the
diﬀerent methods followed for data analysis (CD diagnosis
sens. 84%, spec. 95% [19]; location and extension sens. 88%,
spec. 88% [7]; disease activity and severity sens. 81%, spec.
88% [7] or sens 89%, spec 80% [50]; complication sens.
81%,spec.98%[7];extraintestinalcomplicationssens.100%
[50]).
Moreover, for the identiﬁcation of abscesses, accuracy is
higherforCT(92%)thanforUS(87%)becausefalsepositive
results in US studies [7] and signiﬁcant correlations are ob-
served between the intensity of various CT changes and the
severity of endoscopic lesions [51].
For these reasons, by deﬁning universal procedures (e.g.,
patient’s preparation, performing techniques, diagnostic
s t a n d a r d sf o rI B D ,e t c . )w ew i l lb ea b l et oi n c r e a s es e n s i t i v i t y
and speciﬁcity values in addition to being able to establish
a more accurate diagnosis in order to establish therapy pro-
grams which suit the individual’s needs [37].
To date MDCT-E is indicated in case of patient with ini-
tial diagnosis of Crohn’s disease, suspected complications or
recurrence [39].Gastroenterology Research and Practice 7
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Figure 5: MDCT-E. Intraintestinal ﬁndings: intramural (a), (b) wall thickening (b) (“double halo sign”), (c) hyperemia of the mucosa,
(d) ulcer, (e) stenosis, extramural (f) engorgement of vasa recta (“comb sign”). Extraintestinal ﬁndings: (g), (h) lymph nodes involvement
and mesenteric fat stranding, (i) abscess.
6. MRI Enteroclysis(MR-E)
MRI enteroclysis is a noninvasive, nonionizing radiation dia-
gnostic technique able to obtain multiplanar diagnostic
information about intra- and extraintestinal lesions and eva-
luate disease activity [43].
The high soft-tissue contrast, multiplanar capabilities
and possibility of obtaining functional information make
MR imaging the ideal technique for evaluating small-bowel
inﬂammatory disease (sens. 78%, spec. 85% [7]; sens. 93%,
spec. 93% [19]).
In addition, MR imaging has the advantage over tradi-
tional techniques of visualizing the entire thickness of the
bowel wall and the perivisceral loose connective tissue [53–
55].
Some technical aspects, in particular distension of the
bowel and use of a luminal contrast, may aﬀect the accuracy
of MRI for assessing changes associated with active disease
such as wall thickening and enhancement of bowel wall after
MRI contrast administration [56].
However, the study protocol has not yet been standard-
ized, and some controversy remains regarding the value of
nasoenteric intubation [57].
Some authors [58] suggest that although bowel disten-
sionisgreaterinpatientsundergoingMRenteroclysisthanin
patients undergoing MR enterography, this produces no sig-
niﬁcant diﬀerence between the two groups.
Nevertheless, MR enteroclysis (sens. 90%, spec. 100%)
proved to be more eﬀective than MR enterography (sens
89%, spec 67%) in evaluating stenosis and its signiﬁcance
and also in evaluating bowel-wall thickness (Figure 6)[ 59],
andexaminationwiththeuseofperoralcontrastagentadmi-
nistration may not be accurate for detection of early mucosal
lesions of CD [50].
Moreover, this method is less accurate in the detection of
asmall-bowelstricture,especiallyapartiallyobstructingstri-
cture [50].
In our experience, two days prior to the examination, all
patients take a 2,000cc solution of polyethylene glycol (PEG)
in water (SELG 2000, Milan, Italy) to cleanse the bowel and
are invited to follow a semiliquid diet and on the day of the
examination to have nothing by mouth. Allergic patients
undergo desensitisation therapy with cortisone and antihis-
tamines for 3 days prior to MR examination [60].
Distension of the small bowel is obtained with the
administrationofan1,800ccsolutionofPEGinwater(SELG
2000). The solution is injected via the nasoenteric tube after
they have entered the scanner (MR enteroclysis).
Patients are premedicated with 20mg i.v. of hyoscine N-
butylbromide to reduce intestinal peristalsis and segmenta-
tion of the bowel loops during the examination and are ima-
ged in the prone position with a 1.5-T MR scanner (Magne-
tom Symphony, Siemens, Germany) and phased-array body
coils.
The study protocol includes unenhanced and enhanced
scans (Figures 7 and 8) and the postcontrast acquisitions are
processed, and the time-intensity (T/I) curves are evaluated
(Figure 9).
MR enteroclysis—thanks to the adequate distension it
provides all bowel loops, including the jejunum and the
proximal small-bowel loops—is the technique that best
enables accurate assessment of Crohn’s disease (sens. 74%,8 Gastroenterology Research and Practice
(a) (b)
Figure 6: MR-E. (a), (b) Coronal true fast induction steady-state potential and single-shot hydrographic sequence showing a suitable degree
of jejunum distension.
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 7: MR-E. Last ileal loop wall thickening (a), (b) axial TRUFI T2. (c), (d) Coronal TRUFI T2. (e) Coronal FLASH 3D. (f), (g), (h)
Coronal FLASH 3D postcontrast medium.
spec. 91%) [7]. The technique, in fact, enables identiﬁcation
of lesions to the mucosa and complications. MR enteroclysis
enables identiﬁcation of a stenotic segment, evaluation of
signiﬁcance or insigniﬁcance, deﬁnition of characteristics—
whether inﬂammatory or ﬁbrous—and therefore guidance
towards the most appropriate treatment. The possibility of
obtaining dynamic-functional information, which can only
be achieved with MR enteroclysis, makes it a unique imaging
modality [61].
The correlation for the assessment of activity between
endoscopy and MR and diﬀerentiation between mild and
severe lesions is considered very high [7].
The main drawbacks are represented by high operating
costs and the need for contrast injection. It also has relativelyGastroenterology Research and Practice 9
(a) (b)
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Figure 8: MR-E. Crohn’s disease: colon involvement (a), (b) coronal TRUFI T2 showing (c) axial TRUFI T2; (d) coronal TRUFI T2.
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220
129.5
39
(min.sec) 
0.5 1.4 3.2 2.3 4.1 5
Normal time
−0.4
(b)
Figure 9: MR-E. (a) Coronal TRUFI T2 showing ileal loop wall thickening. (b) Intensity/time curve not showing inﬂammatory activity.
lower sensitivity than MDCT-E (60% versus 89% in the asse-
ssment of bowel-wall thickening only) [59].
However, MRI can detect the most relevant ﬁndings
in patients with IBD with an accuracy superior to that of
enteroclysis (sens. diagnosis 95.2%, abscesses 77.8%, ﬁstulae
70.6%) [62].
To date, the elevated soft-tissue contrast and the func-
tional information it can provide make MR imaging an10 Gastroenterology Research and Practice
Table 1: Imaging techniques features in Crohn’s disease.
Invasiveness IV
infusion
Nasoenteric
tube
Well
accepted
Widely
available
Operator
dependent
Radiation
exposure
Superﬁcial
lesion
detection
Intra/
extraintestinal
structures
Activity of
disease
CE + − + − + − ++ −−
US −−−++ + −− − −
PD −−−++ + −− − −
CEUS − + − + − + −− − +
MDCT-E + + + −− − + − ++ / −
MR-E + + + − −−−− ++ / −
TLLS − + −− − − + −− +
CE:conventionalenteroclysis;US:ultrasonography;PD:powerDoppler;CEUS:contrast-enhancedultrasonography;MDCT-E:multidetectorCTenteroclysis;
MR-E: magnetic resonance enteroclysis; TLLS: 99mTc-HMPAO-labeled leukocyte scintigraphy; IV infusion: intravascular infusion.
ideal candidate for diagnosis at a young age and followup of
patients with Crohn’s disease [43, 50, 63].
7.99mTc-HMPAO-Labeled Leukocyte
Scintigraphy (TLLS)
99mTc-HMPAO-labeled leukocyte scintigraphy can identify
the location of the inﬂammation and consequently assess its
activity level.
Therefore, it provides rationale not only when clinical
data and CT data are unclear but also during the assessment
of a previously known inﬂammatory process so as to devise
a suitable therapy program [64].
TLLS, used as a tool to identify location, level of inﬂam-
mation, and level of infection in nuclear medicine can boast
of a well-established tradition. The response to an inﬂamma-
tion or acute infection process is characterized by an increase
inthelocalamountofblood,increasedvascularpermeability
in addition to plasma protein exudation, and leukocyte
stream [65].
During an acute inﬂammation/infection process, we wit-
nessamajorityofpolymorphicnuclearinﬁltratingcellswhile
in chronic inﬂammation/infection cases cellular response
mostlyconcernslymphocytes,monocytes,andmacrophages.
Although Crohn’s disease represents a chronic condition
with a predominant mononuclear inﬁltrate, labeled leuko-
cytes, in the case of leukocytes inﬁltrating at the level of the
mucosa, give operators a clear view of intestinal inﬂamed
tracts during the acute phase of the disease [64].
TLLS has been extensively employed in patients aﬀected
byCrohnsdiseasethroughouttheyearsproducingnotalways
unanimousresultsduetothediﬀerencesamonglabeledcells,
labeling methods, and the type of imaging which is obtained.
Through the years, many labeling methods have been put
forward both in vitro and in vivo. In vivo labeling is easy to
perform and does not require special equipment. It reduces
performing times as well as being well tolerated by patients
because it calls for only one injection. Conversely, the
generally low quality of view obtained by labeling methods
which present great residual decreases the tracer substance
amount needed for tracing diapedesis. As a result, sensitivity
obtainable from this type of examination is lower because
image quality is distinctly inferior.
In vivo labeling can be performed by means of tech-
netium-99m-labeled anti-granulocyte antibodies. The exam
neither requires patient’s preparation nor blood count, nor
doesitneedsubsequentseparationofleukocytecomponents.
In vitro leukocyte labeling, on the other hand, has the
disadvantage of more complex procedures. It also demands
trained staﬀ, well-equipped laboratories for cell labeling in
aseptic conditions not to mention longer performing times.
The undeniable advantage of in vitro labeling is, however,
given by its distinctly higher image quality due to a selective
labeling of granulocytes with lower residual [65].
In our experience, 99mTc-HMPAO-labeled leukocyte
scintigraphy (TLLS) is performed upon in vitro labeling. As
for the whole-body 99mTc-HMPAO-labeled autologous leu-
kocyte scintigraphy, a sample of venous blood of 50mL is
taken through syringes containing 10mL of acid citrate dex-
trose formula A (ACD-A) upon adding 5mL of hydroxyethyl
starch (HES) at 10%. After sedimentation and centrifuga-
tion, a leukocyte button is obtained and then labeled with
740MBq 99mTc-HMPAO (hexamethyl-propyleneamine ox-
ime) (CERETEC GE, Healthcare) [38].
After labeling and quality control, the level of neutro-
phils in suspension is higher than 95%, and cellular activity
reached 99%. Autologous leukocytes are injected intraven-
ously. The actual dose, which is given according to the label-
ing result, ranges from 370 to 555 MBq.
Scintigraphy images are obtained by employing a rectan-
gular dual-head large-ﬁeld-of-view digital gamma camera
equipped with high-resolution and low-energy collimators.
Images are obtained 60 and 180m after labeled leuko-
cytes have been administered again.
Compared to early scan, late scan (3h) has a higher sen-
sitivity (85% versus 100%) and accuracy (85% versus 95%)
in identifying patients with active IBD and in deﬁning IBD
extension [66].
Still front/rear images of the abdomen and pelvis are
acquired. In order to further assess perianal and rectal invol-
vement, a projection of the pelvis is carried out in ﬁve cases,
theaimbeingtoseparatesuchdistricts,whichoverlapduring
anterior projection, from the bladder. So as to have a clearGastroenterology Research and Practice 11
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Figure 10:TLLS.(a)Noinﬂammatoryactivity;(b)mildinﬂammatoryactivity;(c)moderateinﬂammatoryactivity;(d)severeinﬂammatory
activity.
view of the liver and transverse colon, the anterior projec-
tions of the standing patient’s abdomen are acquired.
In the last few years, technetium-labeled hexamethyl-
propyleneamine oxime scintigraphy (99mTc-HMPAO) has
proved itself to be extremely useful in the diagnosis and fol-
lowuptoCrohn’sdisease.Thereareagreatnumberofadvan-
tages to it, for instance, high sensitivity and speciﬁcity, low
invasiveness, the possibility of performing the exam even in
theacutephaseofthedisease,theopportunitytoperformthe
exam even without bowel cleansing, the further opportunity
to evaluate the seriousness of the process and multifocality
at the same time, lack of risks or contraindications, no side
eﬀects, and good tolerance on the part of the patient.
However, procedures are long and complex not to men-
tion the fact that they require blood manipulation and have
low anatomic resolution. Moreover, 99mTc-HMPAO man-
ages to visualize only acute inﬂammatory cases and may
showfalsepositives(Yersiniaenteritis,ischemiccolitis,tuber-
cularenteritis,rejection,pseudomembranouscolitis,vasculi-
tis, appendicitis, hematomas, radiation enteritis, malignant
pathologies with necrotic component). Crohn’s disease case
studies in nontreated patients report sensitivity percentage
values of 83–98% and speciﬁcity percentage values of
92–100% [64, 65]; particularly in Crohn’s disease diagnosis
sensitivity percentage amounts to 90%, speciﬁcity to 93 [8];
in postsurgical recurrences, diagnostic accuracy percentage
amounts to 81.3–81.8% [23].
Todate,theexistenceof(almost)standardcriteria(asses-
sment of light activity, be it moderate or serious depending
upon the level of the uptake of the bone marrow at the level
of the ileac crests) make it possible for the exam to be rep-
roduced and consequently be valid for identifying the degree
of inﬂammation (Figure 10).
8. Conclusion
Inrecentyears,severalradiologic techniqueshavebeendeve-
loped for the study of the small bowel. Each technique is
characterized by its own proﬁle of advantages and disadvan-
tages (Table 1).Gastroenterology Research and Practice 13
Table 3: Appropriateness of examination in Crohn’s disease.
CE US CPD/CEUS MDCT-E MDCT-e MR-E MR-e TLLS
First diagnosis 8 7 7 9 8 9 8 7
Followup∗ 29 6 2 2 4 5 2
Relapse 6 6 6 8 7 9 8 7
Complications 7 6 6 9 8 9 8 6
9: extremely appropriate; 7-8: usually appropriate; 4–6 doubt; 2-3: usually inappropriate; 1: extremely inappropriate [52].
CE: conventional enteroclysis; US: ultrasonography; PD: power Doppler; CEUS: contrast-enhancement ultrasonography; MDCT-E: multidetector CT
enteroclysis; MDCT-e: multidetector CT enterography; MR-E: magnetic resonance enteroclysis; MR-e: magnetic resonance enterography; TLLS: 99m Tc-
HMPAO-labeled leukocyte scintigraphy; IV infusion: intravascular infusion; ∗negativity of clinic and laboratory exams.
BecauseoftherelapsingnatureofCrohn’sdiseaseandthe
young age at which it usually develops, frequent reevaluation
of disease is necessary in many patients.
Speciﬁc, noninvasive, well-tolerated, and inexpensive ex-
aminations should be carried out while studying Crohn’s
disease. These examinations willhave to conﬁrmclinical sus-
picion of the disease as well as provide morphological infor-
mation such as location, extension, or complication and rec-
urrence evolution (Table 2).
Examinations should also make functional information
available for an eﬀective management of the disease.
In our experience, in the case of initial diagnosis, any in-
vestigation can be used, considering the experience of the
structure and the operator; we propose MDCT, MRE, or CE
for the ﬁrst diagnosis; US, and possibly supplemented with
PD/CEUS, for followup; MRE, MDCT, or TLLS for Relapses;
MDCT, MRE, or CE for complications (Table 3)[ 52].
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